Trails Edge Capital Partners »

Definium Therape shares owned by Trails Edge Capital Partners

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Trails Edge Capital Partners from 13F filings

Historical chart of Trails Edge Capital Partners investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Trails Edge Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Trails Edge Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $33M 1.7M 18.90

More positions owned by Trails Edge Capital Partners

Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Definium Therapeutics Com Shs (DFTX)
Lb Pharmaceuticals Com Shs (LBRX)
Mirum Pharmaceuticals (MIRM)
Nurix Therapeutics (NRIX)
Revolution Medicines (RVMD)
Arcus Biosciences Incorporated (RCUS)
Immunocore Hldgs Ads (IMCR)
Cytokinetics Com New (CYTK)
Syndax Pharmaceuticals (SNDX)
Neurogene (NGNE)
Inventiva Sa Ads (IVA)
Inhibikase Therapeutics Com New (IKT)
4d Molecular Therapeutics In (FDMT)

View all positions for Trails Edge Capital Partners

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Henderson Group
Deep Track Capital
Marshall Wace
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Candriam Luxembourg S.C.A.
Balyasny Asset Management
Two Sigma Investments

View all funds holding Definium Therape